Pub Date : 2021-04-26DOI: 10.15406/OGIJ.2021.12.00561
Jorge Duro Gómez, M. Domínguez, Antonio Jesús de la Torre González, Araceli Lopez Jimenez, Beatriz Pineda Reyes, C. Castelo-Branco
We created 7 groups. Group A started the induction with 10 mg of vaginal dinoprostone and they gave birth during that day. Group B started with 10 mg of vaginal dinoprostone, but the second day they needed another dose of 10 mg of vaginal dinoprostone. Group C: started with 10 mg of vaginal dinoprostone but for 24 hours the cervix was favourable and women continued the induction with oxytocin intravenously until the childbirth. Group D started with 10mg of vaginal dinoprostone the first day, the second they received another dose of 10mg of dinoprostone, and if the cervix was favourable oxytocin was administered. Group E started with 10mg of vaginal dinoprostone and continued with oxytocin the second day. Group F started with 10 mg of vaginal dinoprostone the first day, the second day they needed another dose of dinoprostone, and the third day they continued with oxytocin until the childbirth. Group G: started with oxytocin from the first day, either because the cervix was unfavourable (Bishop Score ≥6), there was a risk of uterine hyperstimulation or because there were contraindications to administer prostaglandins.
{"title":"The results of different labour induction approaches: A Cross sectional study","authors":"Jorge Duro Gómez, M. Domínguez, Antonio Jesús de la Torre González, Araceli Lopez Jimenez, Beatriz Pineda Reyes, C. Castelo-Branco","doi":"10.15406/OGIJ.2021.12.00561","DOIUrl":"https://doi.org/10.15406/OGIJ.2021.12.00561","url":null,"abstract":"We created 7 groups. Group A started the induction with 10 mg of vaginal dinoprostone and they gave birth during that day. Group B started with 10 mg of vaginal dinoprostone, but the second day they needed another dose of 10 mg of vaginal dinoprostone. Group C: started with 10 mg of vaginal dinoprostone but for 24 hours the cervix was favourable and women continued the induction with oxytocin intravenously until the childbirth. Group D started with 10mg of vaginal dinoprostone the first day, the second they received another dose of 10mg of dinoprostone, and if the cervix was favourable oxytocin was administered. Group E started with 10mg of vaginal dinoprostone and continued with oxytocin the second day. Group F started with 10 mg of vaginal dinoprostone the first day, the second day they needed another dose of dinoprostone, and the third day they continued with oxytocin until the childbirth. Group G: started with oxytocin from the first day, either because the cervix was unfavourable (Bishop Score ≥6), there was a risk of uterine hyperstimulation or because there were contraindications to administer prostaglandins.","PeriodicalId":19389,"journal":{"name":"Obstetrics & Gynecology International Journal","volume":"72 1","pages":"108-111"},"PeriodicalIF":0.0,"publicationDate":"2021-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87845348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-04-26DOI: 10.15406/OGIJ.2021.12.00562
Md Shariful Islam, TH Johora Moon Moon, Masuma Amanullah, N. Akhter, M. Moniruzzaman, Md Abdullah Hil Kafi Khan
Cardiovascular disease (CVD) is one of the leading causes of death worldwide which is more prevalent in women after menopause. Hormonal changes associated with menopause are accountable for dyslipidemia pattern that causes CVD and associated complications. Therefore, the present study was commenced to compare the lipid profile in pre- and postmenopausal women. A total of 100 samples were collected from women, 50 from premenopausal and 50 from postmenopausal women, and analyzed for Total Cholesterol (TC), Triglyceride (TG), High-Density Lipoprotein (HDL) and Low-Density Lipoprotein (LDL-). TC, TG, HDL, and LDL were highly significantly increased in postmenopausal women when compared to premenopausal women. DL/HDL ratio was significantly elevated in postmenopausal women than in premenopausal women. MI was significantly positively correlated with TC and TG in both pre- and postmenopausal population and it was positively correlated with HDL in the premenopausal population while negatively correlated in the postmenopausal population. Since more of the atherogenic lipid parameters are increased in postmenopausal women, they appear to be more prone to have CVD and associated complications in the near future. Hence, it is mandatory to monitor and manage dyslipidemia patterns in every woman experiencing menopause. To investigate whether menopause may induce left ventricular structural and functional adaptations in normotensive and hypertensive women, we compared in a case-control setting 50 untreated hypertensive premenopausal women with 50 postmenopausal women and 50 normotensive premenopausal women with 50 postmenopausal women. Subjects were individually physically examined & matched by age (38.2±5.9years to 50±1.03years), clinic systolic blood pressure (128.6±1.05mm Hg & 134±1.2mm Hg), clinic diastolic blood pressure (74.6±1.3mm Hg & 74.6±1.2mm Hg), and body mass index (55.3±8.8kg to 55.6±5.9kg) respectively. We conclude that menopause is associated with blunted day-night blood pressure reduction, impaired left the ventricular systolic performance, and concentric left ventricular geometric pattern. These findings are independent of the presence or absence of high blood pressure.
{"title":"Early cardiac change after menopause-an open level comparative study","authors":"Md Shariful Islam, TH Johora Moon Moon, Masuma Amanullah, N. Akhter, M. Moniruzzaman, Md Abdullah Hil Kafi Khan","doi":"10.15406/OGIJ.2021.12.00562","DOIUrl":"https://doi.org/10.15406/OGIJ.2021.12.00562","url":null,"abstract":"Cardiovascular disease (CVD) is one of the leading causes of death worldwide which is more prevalent in women after menopause. Hormonal changes associated with menopause are accountable for dyslipidemia pattern that causes CVD and associated complications. Therefore, the present study was commenced to compare the lipid profile in pre- and postmenopausal women. A total of 100 samples were collected from women, 50 from premenopausal and 50 from postmenopausal women, and analyzed for Total Cholesterol (TC), Triglyceride (TG), High-Density Lipoprotein (HDL) and Low-Density Lipoprotein (LDL-). TC, TG, HDL, and LDL were highly significantly increased in postmenopausal women when compared to premenopausal women. DL/HDL ratio was significantly elevated in postmenopausal women than in premenopausal women. MI was significantly positively correlated with TC and TG in both pre- and postmenopausal population and it was positively correlated with HDL in the premenopausal population while negatively correlated in the postmenopausal population. Since more of the atherogenic lipid parameters are increased in postmenopausal women, they appear to be more prone to have CVD and associated complications in the near future. Hence, it is mandatory to monitor and manage dyslipidemia patterns in every woman experiencing menopause. To investigate whether menopause may induce left ventricular structural and functional adaptations in normotensive and hypertensive women, we compared in a case-control setting 50 untreated hypertensive premenopausal women with 50 postmenopausal women and 50 normotensive premenopausal women with 50 postmenopausal women. Subjects were individually physically examined & matched by age (38.2±5.9years to 50±1.03years), clinic systolic blood pressure (128.6±1.05mm Hg & 134±1.2mm Hg), clinic diastolic blood pressure (74.6±1.3mm Hg & 74.6±1.2mm Hg), and body mass index (55.3±8.8kg to 55.6±5.9kg) respectively. We conclude that menopause is associated with blunted day-night blood pressure reduction, impaired left the ventricular systolic performance, and concentric left ventricular geometric pattern. These findings are independent of the presence or absence of high blood pressure.","PeriodicalId":19389,"journal":{"name":"Obstetrics & Gynecology International Journal","volume":"293 1","pages":"113-117"},"PeriodicalIF":0.0,"publicationDate":"2021-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79669963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-04-14DOI: 10.15406/OGIJ.2021.12.00559
Jorge Duro Gómez, Justo Martínez León, A. Marin, Rosalba Fuentes
Objective: to describe the obstetric outcomes in patients with an active induction of labor (IOL). Methods: 1037 deliveries were included. In case of IOL, women with unfavorable cervix (Bishop≤6) start with 2 tablets of 25mcg vaginal misoprostol followed by a new tablet every 4 hours up to a maximum of 4 doses. In case of any contraindication for misoprostol a 10mg tablet of dinoprostone was inserted into the vagina. In any case, a cardiotocographic record during 30 minutes was performed previous to each dose. When Bishop was >6, artificial rupture of membranes and oxytocin stimulation was performed. Results: Of 351 spontaneous deliveries, 57 (16.24%) were urgent cesarean section, 211 (60.11%) were eutocic, 58 (7.12%) ended by forceps and 58 (16.52%) by vacuum. Among the IOL (556), 127 (22.84%) completed the delivery by urgent cesarean section, 291(52.33%) were eutocic, 55 (9.89%) ended by forceps and 81 (14.56%) by vacuum Conclusion: the active attitude during the IOL favors results similar to those when the delivery is spontaneous.
{"title":"Obstetric outcomes really worse with the induction of labor","authors":"Jorge Duro Gómez, Justo Martínez León, A. Marin, Rosalba Fuentes","doi":"10.15406/OGIJ.2021.12.00559","DOIUrl":"https://doi.org/10.15406/OGIJ.2021.12.00559","url":null,"abstract":"Objective: to describe the obstetric outcomes in patients with an active induction of labor (IOL). Methods: 1037 deliveries were included. In case of IOL, women with unfavorable cervix (Bishop≤6) start with 2 tablets of 25mcg vaginal misoprostol followed by a new tablet every 4 hours up to a maximum of 4 doses. In case of any contraindication for misoprostol a 10mg tablet of dinoprostone was inserted into the vagina. In any case, a cardiotocographic record during 30 minutes was performed previous to each dose. When Bishop was >6, artificial rupture of membranes and oxytocin stimulation was performed. Results: Of 351 spontaneous deliveries, 57 (16.24%) were urgent cesarean section, 211 (60.11%) were eutocic, 58 (7.12%) ended by forceps and 58 (16.52%) by vacuum. Among the IOL (556), 127 (22.84%) completed the delivery by urgent cesarean section, 291(52.33%) were eutocic, 55 (9.89%) ended by forceps and 81 (14.56%) by vacuum Conclusion: the active attitude during the IOL favors results similar to those when the delivery is spontaneous.","PeriodicalId":19389,"journal":{"name":"Obstetrics & Gynecology International Journal","volume":"43 1","pages":"100-101"},"PeriodicalIF":0.0,"publicationDate":"2021-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83690257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-04-01DOI: 10.15406/OGIJ.2021.12.00558
M. S. França, A. Hatanaka, A. Moron
Cervical pessary is a new treatment for preterm birth and have obtained a lot of space in clinical practice because its real efficacy, which unconsidered the bias produced by some research. There is a lack of evidence about cervical pessary in many aspects and only those who handle this device every day can note and call for attention. Experience is the central point about cervical pessary in this article, and important centers with training and expertise must be taken the front of this issue, because low experience probably is one of the causes of contradictory results in literature. In fact, we have a lot of aspects that need attention and never were treated because always the efficacy is questioned and do not open space for other important aspects. We have a lot of o issues to discuss during this article such as the indication of a cervical pessary, the needs of guidelines about pessary, including a learning curve of pessary treatment, the relevant aspects about insertion of the device, its association with other medications, needs for hospitalization, which is the best management for the vaginal discharge pessary related, how to handle the pelvic pain after insertion, the urinary symptoms, the obstipation, and the inhibition of preterm labor during pessary treatment, and finally, what are the relevant aspects about the withdrawal of cervical pessary?
{"title":"The importance of experience in using cervical pessary for prevention of preterm birth","authors":"M. S. França, A. Hatanaka, A. Moron","doi":"10.15406/OGIJ.2021.12.00558","DOIUrl":"https://doi.org/10.15406/OGIJ.2021.12.00558","url":null,"abstract":"Cervical pessary is a new treatment for preterm birth and have obtained a lot of space in clinical practice because its real efficacy, which unconsidered the bias produced by some research. There is a lack of evidence about cervical pessary in many aspects and only those who handle this device every day can note and call for attention. Experience is the central point about cervical pessary in this article, and important centers with training and expertise must be taken the front of this issue, because low experience probably is one of the causes of contradictory results in literature. In fact, we have a lot of aspects that need attention and never were treated because always the efficacy is questioned and do not open space for other important aspects. We have a lot of o issues to discuss during this article such as the indication of a cervical pessary, the needs of guidelines about pessary, including a learning curve of pessary treatment, the relevant aspects about insertion of the device, its association with other medications, needs for hospitalization, which is the best management for the vaginal discharge pessary related, how to handle the pelvic pain after insertion, the urinary symptoms, the obstipation, and the inhibition of preterm labor during pessary treatment, and finally, what are the relevant aspects about the withdrawal of cervical pessary?","PeriodicalId":19389,"journal":{"name":"Obstetrics & Gynecology International Journal","volume":"18 1","pages":"94-98"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86598527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-03-29DOI: 10.15406/OGIJ.2021.12.00557
Alexis A. Svokos, Jino Park, S. Toms
Ovarian cancer is a leading cause of morbidity and mortality amongst gynecologic malignancies. Due to the lack of screening tests and early detection, most cases of ovarian cancer are diagnosed in advanced stages. Treatment of patients includes multidisciplinary approaches that include surgical debulking and chemoradiation therapy. Recently, there have been emerging clinical trials that are investigating the use of Tumor treating fields (TTFields) in the treatment of patients with ovarian cancer. Tumor treating fields (TTFields) are a novel, non-invasive cancer treatment modality targeted towards inhibition of solid tumor growth.1,2 The use of TTFields was initially approved by the US Food and Drug Administration (FDA) for treatment of recurrent glioblastoma multiforme. In this article, we will be providing an overview of TTFields, including its mechanism of action, burgeoning application in the management of solid tumors, and promising potential in the treatment of patients with platinum resistant ovarian cancer.
{"title":"A review of Tumor Treating Fields and their future implication in treatment of platinum resistant ovarian cancer","authors":"Alexis A. Svokos, Jino Park, S. Toms","doi":"10.15406/OGIJ.2021.12.00557","DOIUrl":"https://doi.org/10.15406/OGIJ.2021.12.00557","url":null,"abstract":"Ovarian cancer is a leading cause of morbidity and mortality amongst gynecologic malignancies. Due to the lack of screening tests and early detection, most cases of ovarian cancer are diagnosed in advanced stages. Treatment of patients includes multidisciplinary approaches that include surgical debulking and chemoradiation therapy. Recently, there have been emerging clinical trials that are investigating the use of Tumor treating fields (TTFields) in the treatment of patients with ovarian cancer. Tumor treating fields (TTFields) are a novel, non-invasive cancer treatment modality targeted towards inhibition of solid tumor growth.1,2 The use of TTFields was initially approved by the US Food and Drug Administration (FDA) for treatment of recurrent glioblastoma multiforme. In this article, we will be providing an overview of TTFields, including its mechanism of action, burgeoning application in the management of solid tumors, and promising potential in the treatment of patients with platinum resistant ovarian cancer.","PeriodicalId":19389,"journal":{"name":"Obstetrics & Gynecology International Journal","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84522549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-03-26DOI: 10.15406/OGIJ.2021.12.00556
H. Ling
Introduction: Pregnant women have more risk for Bell´s palsy compared to non-pregnant women. The majority of cases occur in the third semester of the immediate period post-partum. In traditional Chinese medicine, Bell´s palsy occurs due to the invasion of the external pathogenic factor Wind-Cold attacking the face´s channel. The purpose of this study is to demonstrate why women in post-partum period had more propensity to Bell’s palsy and that the patient has chakras’ energy deficiencies that leads to propensity to develop this problem. Methods: through one case report, 36 years old women who had cesarean section in on November 14th 2020. She wakes up in the next day with the face completely deviated to the right side and cannot close her eyelid in the right eye. She searched for Western medicine physician that orientate her to intake corticosteroids. She went to the author´s clinic and told the doctor that she always turns on the fan on top of her because she was felling much hot in her body during the pregnancy and after the partum. The treatment consisted in Chinese dietary counseling, auricular and systemic acupuncture. It was orientated to restart to intake the homeopathies, crystal based medications that was recommended to her one year ago, and she stopped to intake during the pregnancy. Results: After the first acupuncture session, her face improved very well (50 percent) and she could smile and move the tongue, close her right eyelid better, and the deviation reduced completely using three acupuncture sessions. She also was orientated to avoid raw foods, cold water and walk barefoot and dry the hair after washing it and avoid to go outside her home during the guard period (for a period of 40 days). Conclusion: Women in the post-partum period has more propensity to develop Bell´s palsy because they lost very much Blood and other fluids during the child-birth and usually loose much energy in this process weakening the body and had more propensity to the invasion of Cold and Wind, generation in this form, Bell´s palsy symptoms.
{"title":"Traditional Chinese medicine in the treatment of postpartum bell´s palsy","authors":"H. Ling","doi":"10.15406/OGIJ.2021.12.00556","DOIUrl":"https://doi.org/10.15406/OGIJ.2021.12.00556","url":null,"abstract":"Introduction: Pregnant women have more risk for Bell´s palsy compared to non-pregnant women. The majority of cases occur in the third semester of the immediate period post-partum. In traditional Chinese medicine, Bell´s palsy occurs due to the invasion of the external pathogenic factor Wind-Cold attacking the face´s channel. The purpose of this study is to demonstrate why women in post-partum period had more propensity to Bell’s palsy and that the patient has chakras’ energy deficiencies that leads to propensity to develop this problem. Methods: through one case report, 36 years old women who had cesarean section in on November 14th 2020. She wakes up in the next day with the face completely deviated to the right side and cannot close her eyelid in the right eye. She searched for Western medicine physician that orientate her to intake corticosteroids. She went to the author´s clinic and told the doctor that she always turns on the fan on top of her because she was felling much hot in her body during the pregnancy and after the partum. The treatment consisted in Chinese dietary counseling, auricular and systemic acupuncture. It was orientated to restart to intake the homeopathies, crystal based medications that was recommended to her one year ago, and she stopped to intake during the pregnancy. Results: After the first acupuncture session, her face improved very well (50 percent) and she could smile and move the tongue, close her right eyelid better, and the deviation reduced completely using three acupuncture sessions. She also was orientated to avoid raw foods, cold water and walk barefoot and dry the hair after washing it and avoid to go outside her home during the guard period (for a period of 40 days). Conclusion: Women in the post-partum period has more propensity to develop Bell´s palsy because they lost very much Blood and other fluids during the child-birth and usually loose much energy in this process weakening the body and had more propensity to the invasion of Cold and Wind, generation in this form, Bell´s palsy symptoms.","PeriodicalId":19389,"journal":{"name":"Obstetrics & Gynecology International Journal","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84977159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-03-17DOI: 10.15406/OGIJ.2021.12.00555
M. Alabdulwahab, M. Asiri
The 2019 Coronavirus caused by single stranded RNA virus. Morbidity and mortality are high among pregnant women. Covid 19 vaccine considered safe for adult and protective. Issues of safety raised toward pregnant women and vaccine. The authorization of Covid 19 vaccine for pregnant and nursery women need more studies and trials.
{"title":"Dilemma of COVID19 vaccine during pregnancy","authors":"M. Alabdulwahab, M. Asiri","doi":"10.15406/OGIJ.2021.12.00555","DOIUrl":"https://doi.org/10.15406/OGIJ.2021.12.00555","url":null,"abstract":"The 2019 Coronavirus caused by single stranded RNA virus. Morbidity and mortality are high among pregnant women. Covid 19 vaccine considered safe for adult and protective. Issues of safety raised toward pregnant women and vaccine. The authorization of Covid 19 vaccine for pregnant and nursery women need more studies and trials.","PeriodicalId":19389,"journal":{"name":"Obstetrics & Gynecology International Journal","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73503397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-03-15DOI: 10.15406/OGIJ.2021.12.00554
Dakota Viruega-Cuaresma, Sonia De-Miguel-Manso, E. García-García, Carmen E Badillo-Bercebal, Julio A Gobernado-Tejedor, Marta Pérez-Febles
Objetives: Single incision slings are the latest generation of suburethral bands that seek to minimize morbidity and major complications of transobturator bands. In short and medium term, their results in terms of success and safety are similar to transobturator and retropubic bands. Nevertheless, there is little data on their long-term outcomes. Our objective was to evaluate safety and efficacy of Altis® mini-sling during the short, medium and long-term follow-up. Methods: Prospective observational study in 67 women who underwent surgery with Altis® for a period of 6 years (2013-2019). The main variables evaluated were: total continence, objective cure and subjective cure (satisfaction). The secondary variables studied were: complications and number of pads used per day after surgery. Statistics: Student t-test or U-Mann-Whitney for quantitative variables, Chi-Square for categorical variables. Results: Objective cure rates were: 96.77%, 87.04%, 87.50%, 85.71%, 76.92% and 50% (from 1 to 6years), and total continence: 85.48%, 72.22%, 64.88%, 50%, 46.15% and 50% (from 1 to 6years). Degree of satisfaction was: 9, 8.2, 8.3, 7.7, 7.6 and 6.5 points (from 1 to 6years). 30 patients (44.78%) had some type of complication and the most common were: “de novo” urinary urgency (20.90%), recurrence of stress urinary incontinence (14.93%) and pain (5.97%). Conclusion: Altis® presents high rates of objective and subjective continence in short and medium-term (1-5years), during 6-year follow-up. It is safe and does not associate severe complications. We found a high percentage of “de novo” urgency and recurrence of stress urinary incontinence, especially after the fifth year.
{"title":"Six-year follow-up in patients with urinary stress incontinence treated with Altis® single-incision sling: a prospective single-center study","authors":"Dakota Viruega-Cuaresma, Sonia De-Miguel-Manso, E. García-García, Carmen E Badillo-Bercebal, Julio A Gobernado-Tejedor, Marta Pérez-Febles","doi":"10.15406/OGIJ.2021.12.00554","DOIUrl":"https://doi.org/10.15406/OGIJ.2021.12.00554","url":null,"abstract":"Objetives: Single incision slings are the latest generation of suburethral bands that seek to minimize morbidity and major complications of transobturator bands. In short and medium term, their results in terms of success and safety are similar to transobturator and retropubic bands. Nevertheless, there is little data on their long-term outcomes. Our objective was to evaluate safety and efficacy of Altis® mini-sling during the short, medium and long-term follow-up. Methods: Prospective observational study in 67 women who underwent surgery with Altis® for a period of 6 years (2013-2019). The main variables evaluated were: total continence, objective cure and subjective cure (satisfaction). The secondary variables studied were: complications and number of pads used per day after surgery. Statistics: Student t-test or U-Mann-Whitney for quantitative variables, Chi-Square for categorical variables. Results: Objective cure rates were: 96.77%, 87.04%, 87.50%, 85.71%, 76.92% and 50% (from 1 to 6years), and total continence: 85.48%, 72.22%, 64.88%, 50%, 46.15% and 50% (from 1 to 6years). Degree of satisfaction was: 9, 8.2, 8.3, 7.7, 7.6 and 6.5 points (from 1 to 6years). 30 patients (44.78%) had some type of complication and the most common were: “de novo” urinary urgency (20.90%), recurrence of stress urinary incontinence (14.93%) and pain (5.97%). Conclusion: Altis® presents high rates of objective and subjective continence in short and medium-term (1-5years), during 6-year follow-up. It is safe and does not associate severe complications. We found a high percentage of “de novo” urgency and recurrence of stress urinary incontinence, especially after the fifth year.","PeriodicalId":19389,"journal":{"name":"Obstetrics & Gynecology International Journal","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84775012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-03-11DOI: 10.15406/OGIJ.2021.12.00553
Andrés Mauricio Camacho Montaño, Reinaldo Reinaldo, María Camila Cetina Grajales
Objetives: To report a case of dorsolumbosacral agenesis and to make a systematic review of the literature focused on prenatal diagnosis. Materials and methods: We report a case of a 32year old pregnant woman, with a 30 week pregnanacy, without prenatal care, the fetus is diagnosed with dorsolumbosacral agenesis. The mother request voluntary termination of pregnancy. A systematic review of the literature focused on prenatal diagnosis of thos condiction is performed. Results: We found 50 papers, 6 met the inclusión critiria. Three of them with prenatal diagnosis. In the first case the diagnosis was made at 13 weeks of gestation and termination of preganancy was requested. In the second case corresponded an biamniotic bicorial twin preganancy. One normal feto and one presented dorsolumbosacral agenesis. The diagnosis was made in the second trimester. The pregnancy continued until 34 week of gestation and the affected neonate had perinatal death. The third case, the diagnosis was made at 18 weeks and a male newborn of 2990gr was born at 37 weeks of gestation. Conclusion: Dorsolumbosacral agenesis is a very severe form of caudal regresión syndrome, with only a few cases reportted in the literature. To the best of our knowladge this is the fourth case reported with prenatal diagnosis.
{"title":"Dorsolumbosacral agenesis: Case report and literature review","authors":"Andrés Mauricio Camacho Montaño, Reinaldo Reinaldo, María Camila Cetina Grajales","doi":"10.15406/OGIJ.2021.12.00553","DOIUrl":"https://doi.org/10.15406/OGIJ.2021.12.00553","url":null,"abstract":"Objetives: To report a case of dorsolumbosacral agenesis and to make a systematic review of the literature focused on prenatal diagnosis. Materials and methods: We report a case of a 32year old pregnant woman, with a 30 week pregnanacy, without prenatal care, the fetus is diagnosed with dorsolumbosacral agenesis. The mother request voluntary termination of pregnancy. A systematic review of the literature focused on prenatal diagnosis of thos condiction is performed. Results: We found 50 papers, 6 met the inclusión critiria. Three of them with prenatal diagnosis. In the first case the diagnosis was made at 13 weeks of gestation and termination of preganancy was requested. In the second case corresponded an biamniotic bicorial twin preganancy. One normal feto and one presented dorsolumbosacral agenesis. The diagnosis was made in the second trimester. The pregnancy continued until 34 week of gestation and the affected neonate had perinatal death. The third case, the diagnosis was made at 18 weeks and a male newborn of 2990gr was born at 37 weeks of gestation. Conclusion: Dorsolumbosacral agenesis is a very severe form of caudal regresión syndrome, with only a few cases reportted in the literature. To the best of our knowladge this is the fourth case reported with prenatal diagnosis.","PeriodicalId":19389,"journal":{"name":"Obstetrics & Gynecology International Journal","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83499974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-03-08DOI: 10.15406/OGIJ.2021.12.00552
M. Alalfy, A. Elgazzar, O. Azmy, Ahmed M. Hassan
Objectives: The aim was to make a review on COVID-19 during pregnancy to help in establishment of management plans for pregnant women with corona virus and during labour and postnatal care of the neonates. Methods: Searches were made in PubMed to detect, recent studies regarding COVID–19 during pregnancy. Data were taken out from relevant manuscripts. Conclusion: In comparison to MERS and SARS, COVID-19 seems less lethal, as regard to the inadequate number of cases documented till now. A low-molecular-weight heparin should be given for pregnant women with COVID-19 to reduce the risk of thrombosis.
{"title":"Covid -19 during pregnancy, labour and postnatal: A review article","authors":"M. Alalfy, A. Elgazzar, O. Azmy, Ahmed M. Hassan","doi":"10.15406/OGIJ.2021.12.00552","DOIUrl":"https://doi.org/10.15406/OGIJ.2021.12.00552","url":null,"abstract":"Objectives: The aim was to make a review on COVID-19 during pregnancy to help in establishment of management plans for pregnant women with corona virus and during labour and postnatal care of the neonates. Methods: Searches were made in PubMed to detect, recent studies regarding COVID–19 during pregnancy. Data were taken out from relevant manuscripts. Conclusion: In comparison to MERS and SARS, COVID-19 seems less lethal, as regard to the inadequate number of cases documented till now. A low-molecular-weight heparin should be given for pregnant women with COVID-19 to reduce the risk of thrombosis.","PeriodicalId":19389,"journal":{"name":"Obstetrics & Gynecology International Journal","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74082363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：